| JYHZ2100069 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | License Renew | 2021-04-01 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Completed-Pending Withdrawn | 2021-08-27 | view |
| JYHB2400497 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2024-09-15 | | | | | view |
| JYHB2200454 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2022-08-16 | | | | | view |
| JYHB2200108 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2022-03-02 | | | | | view |
| JYHB2101098 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2021-05-17 | | | | | view |
| JYHB2001101 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2020-06-28 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Filed | 2020-06-30 | view |
| JYHB2000343 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2020-03-30 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Filed | 2020-04-10 | view |
| JYHB2000147 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2020-02-29 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2020-04-20 | view |
| JYHB1901292 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2019-11-09 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2020-01-21 | view |
| JYHB1901274 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2019-11-02 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | In Review | 2019-11-01 | view |
| JYHB1900221 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2019-02-25 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2019-04-12 | view |
| JYHB1800961 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2018-08-15 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2018-10-29 | view |
| JYHB1800647 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2018-06-04 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Filed | 2018-06-15 | view |
| JYHB1800416 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2018-04-21 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2018-07-26 | view |
| JYHB1800048 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2018-02-02 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2018-05-09 | view |
| JYHB1701545 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2017-12-11 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2018-03-26 | view |
| JYHB1701422 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2017-11-20 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2018-03-26 | view |
| JYHB1300947 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs | Supplementary Application | 2013-08-08 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Approval Completed-Pending Certificated | 2014-09-25 | view |
| JXHS2200002 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2022-01-06 | | | | | view |
| JXHS2100011 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-01-27 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2021-01-26 | view |
